TY  - CHAP
M1  - Book, Section
TI  - Thrombotics and Antithrombotics
A1  - Slattery, David E.
A1  - Pollack, Jr, Charles V.
A2  - Tintinalli, Judith E.
A2  - Ma, O. John
A2  - Yealy, Donald M.
A2  - Meckler, Garth D.
A2  - Stapczynski, J. Stephan
A2  - Cline, David M.
A2  - Thomas, Stephen H.
Y1  - 2020
N1  - 
T2  - Tintinalli's Emergency Medicine: A Comprehensive Study Guide, 9e
AB  - Antithrombotic  therapy  (i.e.,  anticoagulants,  antiplatelet  agents,  and  fibrinolytics)  is  used  to  treat  or  reduce  the  risk  of  arterial  and  venous  thromboembolic  conditions,  including  acute  coronary  syndrome,  deep  venous  thrombosis  and  pulmonary  embolism  (collectively,  venous  thromboembolic  disease),  transient  ischemic  attack,  and  ischemic  stroke  (Table  239-1).  Moreover,  antithrombotic  agents  help  prevent  occlusive  vascular  events  in  patients  at  risk  for  thrombosis  due  to  atherosclerotic  arterial  disease,  atrial  fibrillation,  medical  illness  with  immobility,  or  surgical  insult.  These  agents,  however,  can  cause  life-threatening  complications,  primarily  serious  or  life-threatening  hemorrhage.  Detailed  management  strategies  for  thromboembolic  disorders  are  discussed  in  their  respective  chapters  (see  Chapter  49,  “Acute  Coronary  Syndromes”;  Chapter  56,  “Venous  Thromboembolism  Including  Pulmonary  Embolism”;  and  Chapter  167,  “Stroke  Syndromes”).  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1166813100
ER  -